메뉴 건너뛰기




Volumn 25, Issue 16, 2015, Pages 3295-3300

Novel (pyrazolyl)benzenesulfonamides with a nitric oxide-releasing moiety as selective cyclooxygenase-2 inhibitors

Author keywords

Anti inflammatory therapy; Cardiovascular side effects; Celecoxib; Direct indirect NO coupling; Griess assay; Organic nitrate

Indexed keywords

(PYRAZOLYL)BENZENESULFONAMIDE DERIVATIVE; 4 [3 (HYDROXYMETHYL) 5 (PARA TOLYL) 1H PYRAZOL 1 YL]BENZENESULFONAMIDE; ANTIINFLAMMATORY AGENT; BENZENESULFONAMIDE DERIVATIVE; CELECOXIB; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; DICHLORINATED CHLORO [3 (CHLOROMETHYL) 5 (PARA TOLYL) 1H PYRAZOL 1 YL]BENZENESULFONAMIDE; MONOCHLORINATED 4 [3 (CHLOROMETHYL) 5 (PARA TOLYL) 1H PYRAZOL 1 YL]BENZENESULFONAMIDE; NITRIC OXIDE DONOR; ORGANIC NITRATE; UNCLASSIFIED DRUG; [1 (4 SULFAMOYLPHENYL) 5 (PARA TOLYL) 1H PYRAZOL 3 YL]METHYL NITRATE; [4 CHLORO 1 (4 SULFAMOLYPHENYL) 5 (PARA TOLYL) 1H PYRAZOL 3 YL]METHYL NITRATE; BENZENESULFONAMIDE; NITRIC OXIDE; NONSTEROID ANTIINFLAMMATORY AGENT; SULFONAMIDE;

EID: 84934844110     PISSN: 0960894X     EISSN: 14643405     Source Type: Journal    
DOI: 10.1016/j.bmcl.2015.05.059     Document Type: Article
Times cited : (22)

References (31)


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.